Document is current
Any future updates will be listed below
-
Authors
Gale, Robert Peter https://orcid.org/0000-0002-9156-1676
Jiang, Qian https://orcid.org/0000-0001-7131-0522
Apperley, Jane F. https://orcid.org/0000-0002-1710-1794
Hochhaus, Andreas
- License Information
-
More Information
Article History
Received: 4 June 2024
Revised: 7 June 2024
Accepted: 12 June 2024
First Online: 25 June 2024
Competing interests
: RPG is a consultant to Antengene Biotech LLC; Medical Director, FFF Enterprises Inc.; Speaker for Janssen Pharma and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd. JFA Advisory Boards Novartis, Terns, Ascentage; Speaker: Novartis, Incyte, Paladin. Research funding: Pfier, Incyte. AH received research support by Novartis, BMS, Incyte, Pfizer and Enliven Pharma. RPG and AH are Editors-in-Chief of <i>LEUKEMIA</i>.
